✦ LIBER ✦

Two-year glycaemic control and healthcare expenditures following initiation of insulin glargine versus neutral protamine Hagedorn insulin in type 2 diabetes

✍ Scribed by G. G. Rhoads; M. P. Dain; Q. Zhang; L. Kennedy

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The cost-effectiveness of insulin glargi

✍ P. Levin 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

Similar risk of malignancy with insulin

✍ J. Rosenstock; V. Fonseca; J. B. McGill; M. Riddle; J. P. Hallé; I. Hramiak; P. 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 73 KB

Similar progression of diabetic retinopa

✍ J. Rosenstock; V. Fonseca; J. B. McGill; M. Riddle; J.-P. Hallé; I. Hramiak; P. 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 218 KB

Comparison of Safety and Efficacy of Ins

✍ Pearl Lee; Annette Chang; Caroline Blaum; Aleksandra Vlajnic; Ling Gao; Jeffrey 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

Similar progression of diabetic retinopa

✍ J. Rosenstock; V. Fonseca; J. B. McGill; M. Riddle; J.-P. Hallé; I. Hramiak; P. 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 84 KB

Transferring to insulin detemir from NPH

✍ A. Dornhorst; H.-J. Lüddeke; C. Koenen; M. Meriläinen; A. King; A. Robinson; S. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB